Chronic treatment with haloperidol diminishes the phencyclidine-induced sensorimotor gating deficit in rats

被引:0
|
作者
Ma∏gorzata Pietraszek
Krystyna Ossowska
机构
[1] Department of Neuro-Psychopharmacology,
[2] Institute of Pharmacology,undefined
[3] Polish Academy of Sciences,undefined
[4] 12 Sm´tna St.,undefined
[5] PL-31-343 Kraków,undefined
[6] Poland,undefined
关键词
Key words Prepulse inhibition; Phencyclidine; Chronic haloperidol; Antipsychotic action;
D O I
暂无
中图分类号
学科分类号
摘要
Prepulse inhibition is a model in which a weak subthreshold stimulus (prepulse), presented to an individual before a strong stimulus (pulse), inhibits a startle response to the latter. A deficit of prepulse inhibition induced by dopaminomimetics and antagonists of NMDA receptors has been suggested as an animal model of the sensorimotor deficit in schizophrenia. The aim of the present study was to examine the effect of chronic treatment with the classic neuroleptic haloperidol on the disruption of prepulse inhibition induced by the uncompetitive antagonist of NMDA receptors phencyclidine (PCP, 5mg/kg sc). Haloperidol in a dose of 1mg/kg/day was given to rats in drinking water for 3 months. The PCP-induced reduction in prepulse inhibition was not reversed by short-term (4-day) haloperidol administration. In contrast, long-term treatment with haloperidol (6 weeks or 3 months) diminished the PCP-induced effect. The present study suggests that the improvement in sensorimotor gating in the PCP model in rats by prolonged treatment with haloperidol may reflect its antipsychotic action.
引用
收藏
页码:466 / 471
页数:5
相关论文
共 50 条
  • [41] Differential effects of haloperidol on phencyclidine-induced reduction in substance P contents in rat brain regions
    Shirayama, Y
    Mitsushio, H
    Takahashi, K
    Nishikawa, T
    SYNAPSE, 2000, 35 (04) : 292 - 299
  • [42] Muscarinic receptor signaling contributes to atypical antipsychotic drug reversal of the phencyclidine-induced deficit in novel object recognition in rats
    Miyauchi, Masanori
    Neugebauer, Nichole M.
    Sato, Tatsuya
    Ardehali, Hossein
    Meltzer, Herbert Y.
    JOURNAL OF PSYCHOPHARMACOLOGY, 2017, 31 (12) : 1588 - 1604
  • [43] Chronic cannabinoid exposure reduces phencyclidine-induced schizophrenia-like positive symptoms in adult rats
    Maria Sabrina Spano
    Liana Fattore
    Francesca Cadeddu
    Walter Fratta
    Paola Fadda
    Psychopharmacology, 2013, 225 : 531 - 542
  • [44] Phencyclidine-induced abnormal behaviors in rats as measured by the hole board apparatus
    Morita, T
    Sonoda, R
    Nakato, K
    Koshiya, K
    Wanibuchi, F
    Yamaguchi, T
    PSYCHOPHARMACOLOGY, 2000, 148 (03) : 281 - 288
  • [45] Modulation of phencyclidine-induced changes in locomotor activity and patterns in rats by serotonin
    Krebs-Thomson, K
    Lehmann-Masten, V
    Naiem, S
    Paulus, MP
    Geyer, MA
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 343 (2-3) : 135 - 143
  • [46] EFFECTS OF ETHANOL ON PHENCYCLIDINE-INDUCED ANALGESIA AND LOCOMOTOR-ACTIVITY IN RATS
    BUSH, DM
    MATTIA, A
    CAPLAN, YH
    MORETON, JE
    FEDERATION PROCEEDINGS, 1987, 46 (03) : 399 - 399
  • [47] Phencyclidine-induced abnormal behaviors in rats as measured by the hole board apparatus
    T. Morita
    R. Sonoda
    K. Nakato
    K. Koshiya
    F. Wanibuchi
    T. Yamaguchi
    Psychopharmacology, 2000, 148 : 281 - 288
  • [48] Involvement of the serotonergic neuronal system in phencyclidine-induced place aversion in rats
    Kitaichi, K
    Noda, Y
    Miyamoto, Y
    Numaguchi, A
    Osawa, H
    Hasegawa, T
    Furukawa, H
    Nabeshima, T
    BEHAVIOURAL BRAIN RESEARCH, 1999, 103 (01) : 105 - 111
  • [49] Reelin has a preventive effect on phencyclidine-induced cognitive and sensory-motor gating deficits
    Ishii, Kazuhiro
    Nagai, Taku
    Hirota, Yuki
    Noda, Mariko
    Nabeshima, Toshitaka
    Yamada, Kiyofumi
    Kubo, Ken-ichiro
    Nakajima, Kazunori
    NEUROSCIENCE RESEARCH, 2015, 96 : 30 - 36
  • [50] PHENCYCLIDINE-INDUCED WET-DOG SHAKES OBSERVED IN RATS AFTER WITHDRAWAL FROM RESERPINE TREATMENT
    NABESHIMA, T
    YAMAGUCHI, K
    YOSHIDA, S
    FURUKAWA, H
    KAMEYAMA, T
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1986, 24 (05) : 1275 - 1279